Madarosis is characterized by either complete or partial loss of eyebrow or eyelash hair.
Etiologies for madarosis are varied, and accurate diagnosis is the first step in clinical …

Although progress has been made in developing outcome measures for AA, the use of these
measures remains unstandardized. A scoping review was conducted to identify the clinician …

Clinician-reported outcome measures (ClinROMs) are an important part of disease
assessment in daily practice and clinical trials. There is a broad disagreement on the most …

Background A set of criteria for severity classification is essential in alopecia areata (AA).
Currently, no guidelines are universally accepted for defining AA severity. Objective This …

Background Alopecia areata (AA) is characterized by hair loss on the scalp and body,
significantly impacting patients' quality of life based on its severity. Objective This study aims …

Alopecia areata (AA) is the most frequent type of non-scarring alopecia after androgenetic
alopecia. The lifetime risk of developing AA is approximately 1.7–2.1%, and its incidence is …